Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[PPAR and diabetes].

Yasuo Terauchi1, Takashi Kadowaki

  • 1Department of Metabolic Diseases, Graduate School of Medicine, University of Tokyo.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|April 15, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mechanism for increased hepatic glycerol synthesis in the citrin/mitochondrial glycerol-3-phosphate dehydrogenase double-knockout mouse: Urine glycerol and glycerol 3-phosphate as potential diagnostic markers of human citrin deficiency.

Biochimica et biophysica acta·2015
Same author

Hemoglobin a1c levels and the risk of cardiovascular disease in people without known diabetes: a population-based cohort study in Japan.

Medicine·2015
Same author

A Novel Peroxisome Proliferator-activated Receptor (PPAR)α Agonist and PPARγ Antagonist, Z-551, Ameliorates High-fat Diet-induced Obesity and Metabolic Disorders in Mice.

The Journal of biological chemistry·2015
Same author

DialBetics With a Multimedia Food Recording Tool, FoodLog: Smartphone-Based Self-Management for Type 2 Diabetes.

Journal of diabetes science and technology·2015
Same author

Brachial-ankle pulse wave velocity is associated with coronary calcification among 1131 healthy middle-aged men.

International journal of cardiology·2015
Same author

Safety and efficacy of teneligliptin in Japanese patients with type 2 diabetes mellitus: a pooled analysis of two Phase III clinical studies.

Expert opinion on pharmacotherapy·2015
Same journal

[Development of novel therapeutics for multiple myeloma and improvement of drug lag].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Clinical pharmacy services to patients of immunomodulatory drugs].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Therapeutic drug monitoring of the new anti-myeloma drugs in the treatment of multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Prognostic value of minimal residual disease assessment using next-generation sequencing in multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[The evaluation of minimal residual disease in multiple myeloma by an allele-specific oligonucleotide real-time PCR].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Evaluation of minimal residual disease in myeloma by multiparametric flow cytometry].

Nihon rinsho. Japanese journal of clinical medicine·2019
See all related articles

Peroxisome proliferator-activated receptors (PPARs) are key nuclear receptors regulating metabolism. Understanding their mechanisms and targets offers insights into metabolic diseases like diabetes and informs drug design.

Area of Science:

  • Biochemistry and Molecular Biology
  • Endocrinology
  • Metabolic Research

Context:

  • Peroxisome proliferator-activated receptors (PPARs) are nuclear receptors involved in fatty acid metabolism.
  • Dysregulation of PPARs is linked to metabolic diseases including hyperlipidemia, insulin resistance, and diabetes.
  • The three subtypes (PPARα, PPARγ, PPARδ) exhibit distinct tissue expression and functions.

Purpose:

  • To elucidate the regulatory mechanisms of PPARs.
  • To identify the transcriptional targets of PPAR subtypes.
  • To understand the role of PPARs in metabolic homeostasis and disease pathogenesis.

Summary:

  • PPARα promotes hepatic fatty acid catabolism, targeted by fibrates.
  • PPARγ is crucial for adipocyte differentiation and insulin sensitization, targeted by thiazolidinediones.

Related Experiment Videos

  • PPARδ influences lipid metabolism and body weight regulation in adipose tissues.

    • Impact:

    • Provides insights into the pathogenesis of metabolic diseases.
    • Offers valuable information for the rational drug design of metabolic disease therapeutics.
    • Highlights the therapeutic potential of targeting PPARs for conditions like diabetes and hyperlipidemia.